Charmacy Pharmaceutical Co., Ltd. appointed Zhang Hanzi (as an executive Director with effect from the date of the EGM until the expiration of the term of the third session of the Board and she is eligible for re-election upon expiry of her term. The Company will enter into a letter of appointment with Ms. Zhang. Ms. Zhang's annual salary as an executive Director is RMB50,000, which is determined with reference to her qualifications, experiences, duties and responsibilities within the Company as well as the prevailing market rate for candidates with comparable qualifications. The profile of Ms. Zhang has been set out in the Circular. As at the date of this announcement, there has been no
change in such information. Save as disclosed in the Circular, as at the date of this announcement, Ms. Zhang has confirmed that (i) she has not held any directorship in any other public company in the past three years whose securities are listed in Hong Kong or any overseas securities market; (ii) she has no relationship with any Director, supervisor, senior management or substantial or controlling shareholder of the Company, nor has she held any position in the Company or any of its subsidiaries; (iii) she has no interests in the Shares within the meaning of Part XV of the Securities and Futures Ordinance of Hong Kong (Chapter 571 of the Laws of Hong Kong); and (iv) there is no other information in relation to Ms. Zhang which is required to be disclosed pursuant to Rule 13.51(2)(h) to (v) of the Listing Rules, nor are there other matters in relation to her appointment that need to be brought to the attention of the Shareholders. The Board announced that Ms. Fu Zheng ("Ms. Fu") has been appointed as a non-executive Director with effect from the date of the EGM until the expiration of the term of the third session of the Board and she is eligible for re-election upon expiry of her term. The Company will enter into a letter of appointment with Ms. Fu. Ms. Fu will not receive any remuneration for serving as a non-executive Director. The profile of Ms. Fu has been set out in the Circular. As at the date of this announcement, there has been no change in such information. Save as disclosed in the Circular, as at the date of this announcement, Ms. Fu has confirmed that
(i) she has not held any directorship in any other public company in the past three years whose securities are listed in Hong Kong or any overseas securities market; (ii) she has no relationship with any Director, supervisor, senior
management or substantial or controlling shareholder of the Company, nor has she held any position in the Company or any of its subsidiaries; (iii) she has no interests in the Shares within the meaning of Part XV of the Securities and Futures Ordinance of Hong Kong (Chapter 571 of the Laws of Hong Kong); and (iv) there is no other information in relation to Ms. Fu which is required to be disclosed pursuant to Rule 13.51(2)(h) to (v) of the Listing Rules, nor are there other matters in relation to her appointment that need to be brought to the attention of the Shareholders.